Denna sida har översatts automatiskt och översättningens korrekthet kan inte garanteras. Vänligen se engelsk version för en källtext.

Comorbidities and Health Care Services Utilisation Among Long-term Breast Cancer Survivors (SURBCAN)

19 februari 2019 uppdaterad av: Maria Sala, Parc de Salut Mar
The increased likelihood of survival can be explained by numerous factors, such as improvements in breast cancer screening and advances in diagnosis and treatment and aging. This phenomenon is associated with comorbidity due to cancer treatment and external factors like aging or lifestyle. Little is known about how these women follow-up their disease, their pattern of use of health resources and their met and unmet needs. Studying the health needs of these women is a cancer-related priority for Cancer Organizations.The project is aimed at: 1) Describing the comorbidities and patterns of use of primary and specialized care in women who have survived a breast cancer for at least five years; 2) Comparing the comorbidities and patterns of use of long time breast cancer survivors with women without a cancer diagnosis; and 3) Estimating the use of resources in long time survivors of breast cancer adjusted for survival-time and comorbidities.

Studieöversikt

Status

Avslutad

Betingelser

Detaljerad beskrivning

The general objective of this study is to analyze the pattern of comorbidities and utilization of primary care officers and specialized attention of long-term breast cancer survivors and to compare it with women without history of cancer. Long-term breast cancer survivors are those women who survived for at least five years since de primary breast cancer diagnosis.The use of health care services for long-term breast cancer survivors presents new challenges for health systems in terms of defining the role of each health professional and each level of care in contact with these women during their follow-up.

The SURBCAN Project is an observational study that includes a retrospective cohort of women from five Spanish areas. The study is based on Real World Data from clinical history and tumor registration. Women with a diagnosis of breast cancer and a survival period of ≥ 5 years were identified, as well as those women without a cancer diagnosis and matched by age and area with breast cancer survivors (1:2). N= 21639 women (7241 cases /13,398 controls). Sociodemographic and clinical variables were included. The use of primary care and hospital attention and the presence of comorbidities were assessed during the follow-up period (2012-2016). The basal cohort, the comorbidities and the use of health services were described. Factors associated with use were analyzed through multi-level logistic regression models.

Expected results: Nowadays there are no results of cohort analysis that focus specifically in long-term breast cancer survivors. The SURBCAN study will provide evidence regarding comorbidity patterns and follow-up characteristics. The results will guide the elaboration of new recommendations and the decision making by stakeholders concerned to breast cancer survivor's follow-up.

This project combines the experience from experts groups in health services assessment, and analysis of comorbidities and chronic diseases, belonging to the REDISSEC network.

Studietyp

Observationell

Inskrivning (Faktisk)

21639

Deltagandekriterier

Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.

Urvalskriterier

Åldrar som är berättigade till studier

18 år och äldre (Vuxen, Äldre vuxen)

Tar emot friska volontärer

N/A

Kön som är behöriga för studier

Kvinna

Testmetod

Icke-sannolikhetsprov

Studera befolkning

Women with a diagnosis of breast cancer (during 2000 until 2006) with a survival period of ≥ 5 years that had a visit with the healthcare services during the period from 2012 to 2016 were identified, as well as those women without a cancer diagnosis and matched by age and area with breast cancer survivors.

Beskrivning

Inclusion Criteria:

  • >18 years old
  • Women diagnosed with an incident breast cancer during the period from 01/01/2000 until 31/12/2006 who survived for at least 5 years.
  • Women who visited at least once the primary health services during follow-up period (01/01/2012 to 31/12/2016).

Exclusion Criteria:

- Unknown diagnostic year

Studieplan

Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.

Hur är studien utformad?

Designdetaljer

Kohorter och interventioner

Grupp / Kohort
Long-term breast cancer survivors

Analyze comorbidities and patterns of use of health services. Describe the specific use of health services in primary care vs. specialized care.

Analyze comorbidities and patterns of use of health services by tumor characteristics.
Women without history of cancer
Analyze comorbidities and patterns of use of health services. Describe the specific use of health services in primary care vs. specialized care.

Vad mäter studien?

Primära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Frequency of comorbidities
Tidsram: 5 years of survival
Number of comorbidities of each woman at five-year survival from breast cancer. Assessed through ICD10.
5 years of survival
Frequency of visits to healthcare services
Tidsram: 5 years of survival
Number of visits to primary care attention or specialised attention done by each women at five-year survival from breast cancer.
5 years of survival
Main health provider visited
Tidsram: 5 years of survival
Leading provider of health services (GP, oncologist, community nurse, oncology nurse, physiotherapist...) of each women at five-year survival from breast cancer.
5 years of survival

Sekundära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Frequency of visits to primary care attention
Tidsram: at 5 years of survival
Number of visits to primary care attention done by each women at five-year survival from breast cancer.
at 5 years of survival
Frequency of visits to specialized care attention
Tidsram: at 5 years of survival
Number of visits to specialised attention done by each women at five-year survival from breast cancer.
at 5 years of survival
Annual mammogram frequency
Tidsram: 1 year
Assessment of the percentage of women who have a mammogram every year.
1 year

Samarbetspartners och utredare

Det är här du hittar personer och organisationer som är involverade i denna studie.

Sponsor

Parc de Salut Mar

Samarbetspartners

Fondo de Investigacion Sanitaria
European Regional Development Fund
Red de Investigación en Servicios de Salud en Enfermedades Crónicas

Publikationer och användbara länkar

Den som ansvarar för att lägga in information om studien tillhandahåller frivilligt dessa publikationer. Dessa kan handla om allt som har med studien att göra.

Allmänna publikationer

Studieavstämningsdatum

Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.

Studera stora datum

Studiestart (Faktisk)

1 januari 2012

Primärt slutförande (Faktisk)

1 januari 2012

Avslutad studie (Faktisk)

31 december 2016

Studieregistreringsdatum

Först inskickad

13 februari 2019

Först inskickad som uppfyllde QC-kriterierna

19 februari 2019

Första postat (Faktisk)

20 februari 2019

Uppdateringar av studier

Senaste uppdatering publicerad (Faktisk)

20 februari 2019

Senaste inskickade uppdateringen som uppfyllde QC-kriterierna

19 februari 2019

Senast verifierad

1 februari 2019

Mer information

Termer relaterade till denna studie

Nyckelord

Ytterligare relevanta MeSH-villkor

Andra studie-ID-nummer

  • SURBCAN Project

Läkemedels- och apparatinformation, studiedokument

Studerar en amerikansk FDA-reglerad läkemedelsprodukt

Nej

Studerar en amerikansk FDA-reglerad produktprodukt

Nej

Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .

Kliniska prövningar på Bröstcancer

Sök liknande försök

Sponsorer och medarbetare

Medicinska tillstånd

Läkemedelsinterventioner

CROs by country

CROs in Pakistan

Betingelser

Sällsynta sjukdomar

Läkemedelsinterventioner

Kosttillskott

Sponsor / medarbetare

Platser

3
Prenumerera